Evaro offers a digital health integration platform, providing services such as issuing prescriptions, fulfilling medication, and aftercare support, self-described as making healthcare more accessible and affordable.

Evaro

Cerner Corporation, together with its subsidiaries, provides health care information technology solutions and tech-enabled services in the United States and internationally. It offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers. The company also provides HealtheIntent platform, a cloud-based platform to aggregate, transform, and reconcile data across the continuum of care; and CareAware, an EHR agnostic platform that facilitates connectivity of health care devices to EHRs. In addition, it offers a portfolio of clinical and financial healthcare information technology solutions, as well as departmental and care coordination solutions. Further, the company provides tech-enabled services, such as implementation and training, remote hosting, application management, revenue cycle, support and maintenance, health care data analysis, real-world evidence, clinical process optimization, transaction processing, employer health centers, and data-driven services; and complementary hardware and devices for third parties. It serves integrated delivery networks, physician groups and networks, managed care organizations, hospitals, medical centers, free-standing reference laboratories, home health agencies, blood banks, imaging centers, pharmacies, pharmaceutical manufacturers, employers, governments, and public health organizations. The company was founded in 1979 and is headquartered in North Kansas City, Missouri. As of June 8, 2022, Cerner Corporation operates as a subsidiary of Oracle Corporation.

Metric
Company Name	Evaro	Cerner Corporation
Symbol		CERN
MSH ID	COM:EVARO	COM:CERNER
Market	PRIVATE	STOCKS
Sector	Healthcare & Health Services	Healthcare
Industry	Health Technology	Medical - Healthcare Information Services
Country	GB	US
Stage
Employee Count		25.15K
Website	evaro.com	cerner.com
LinkedIn
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue		5.76B
Revenue (LTM)
Revenue (NTM)
Gross Profit		4.76B
EBITDA		1.46B
Operating Income		742.93M
Net Income		555.60M
EPS		1.81
Diluted EPS		1.81
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score		93.91
28-Day Growth Score		37.24
90-Day Growth Score		46.20
365-Day Growth Score		44.02

Metric
Gross Profit Margin		0.83
Operating Profit Margin		0.13
EBITDA Margin		0.25
Net Profit Margin		0.10
Return on Equity		0.14
Return on Assets		0.07
Return on Capital Employed		0.13

COM:EVARO

Evaro

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio		52.39
P/B Ratio		7.91
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple		-0.85

Metric
Days Sales Outstanding		73.53
Days Payables Outstanding		120.18
Days Inventory Outstanding		10.27
Operating Cycle		83.80
Cash Conversion Cycle		-36.38
Asset Turnover		0.78

Metric
Operating Cash Flow		1.77B
Free Cash Flow		1.14B
Cash Flow to Debt		0.96
Operating Cash Flow/Sales		0.31
Free Cash Flow Yield

Metric
Cash & Equivalents		589.85M
Accounts Receivable
Inventory		28.16M
Goodwill		1.13B
Debt to Capitalization		0.33
Debt to Assets		0.25
Current Ratio		1.51
Quick Ratio		1.23

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue		0.03
R&D to Revenue		0.15
SG&A to Revenue		0.09